Spinout investment by deal count in 2025 is underpinned regions. Its investments in 2025 included Leeds-based by regionally-focused and public capital, alongside aAssetCool, which spun out from the University of the total, indicating that the downturn extends beyond the In 2025, spinouts received f1.96b in equity investment, the lowest total since 2020 and a 45.1% drop from 2024's absence of megadeals. f3.57b. Average investment per deal fell from f7.65m in 2024 to f5.10m in 2025, returning to more typical levelsThis marks a departure from the wider UK equity market, a total of 32 deals in 2025, highlighting the importance after the 2024 spike in average round size. Deal numbers of public capital in anchoring early stage investment,prominently in the rankings, including Parkwalk Advisors in 2025 despite a fallin deal numbers. Nationally, capital particularly outside the South East.Investments included(16 deals), Cambridge Enterprise (10 deals) and Oxford declined to384,the lowest since 2016,diverging from the sustained elevation seen between 2020 and 2024. Dxcover,a biotechnology company that raised f5.04m to Science Enterprises (7 deals), alongside regionally- appears to be concentrated into fewer, larger rounds, develop blood tests for brain cancer detection. favouring more mature, lower-risk companies. By contrast, focused Foresight Group (7 deals). Crowdfunding platform Crowdcube (11 deals) also featured, as did early-stage structural reasons: they are typically younger, IP-intensive Mercia Ventures ranked second, with Mercia-managed funds contributing to 23 deals. Mercia specialises in Syndicate Room (13 deals), together illustrating the breadth representedveraquarterofinvestmentthatyear, spinout companieswithlongerpathstocommercialisation,leaving funding has otherwise declined annually since 2021. them at a disadvantage in a more selective market. regional investment outside London and manages multiple of funder types active in the spinout ecosystem. The two largest deals in 2025 accounted for just 12.9% of